These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 20189193)

  • 1. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
    Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
    J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
    Chung AW; Yang HH; Radomski MW; van Breemen C
    Circ Res; 2008 Apr; 102(8):e73-85. PubMed ID: 18388324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
    Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    Br J Pharmacol; 2009 Nov; 158(6):1503-12. PubMed ID: 19814725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP-2 regulates Erk1/2 phosphorylation and aortic dilatation in Marfan syndrome.
    Xiong W; Meisinger T; Knispel R; Worth JM; Baxter BT
    Circ Res; 2012 Jun; 110(12):e92-e101. PubMed ID: 22550139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
    Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
    Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Naringenin inhibits thoracic aortic aneurysm formation in mice with Marfan syndrome].
    Li ZQ; Yu B; Cai ZY; Wang YB; Zhang X; Zhou B; Fang XH; Yu F; Fu Y; Sun JP; Li W; Kong W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):896-906. PubMed ID: 36241232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
    Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
    Habashi JP; Judge DP; Holm TM; Cohn RD; Loeys BL; Cooper TK; Myers L; Klein EC; Liu G; Calvi C; Podowski M; Neptune ER; Halushka MK; Bedja D; Gabrielson K; Rifkin DB; Carta L; Ramirez F; Huso DL; Dietz HC
    Science; 2006 Apr; 312(5770):117-21. PubMed ID: 16601194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional changes in elastic fiber organization and transforming growth factor β signaling in aortas from a mouse model of marfan syndrome.
    Howell DW; Popovic N; Metz RP; Wilson E
    Cell Tissue Res; 2014 Dec; 358(3):807-19. PubMed ID: 25238995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of β-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome.
    Wisler JW; Harris EM; Raisch M; Mao L; Kim J; Rockman HA; Lefkowitz RJ
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1516-27. PubMed ID: 26371162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox Dysregulation of Vascular Smooth Muscle Sirtuin-1 in Thoracic Aortic Aneurysm in Marfan Syndrome.
    Budbazar E; Sulser Ponce De Leon S; Tsukahara Y; Liu H; Huangfu Y; Wang Y; Seabra PM; Yang X; Goodman JB; Wan X; Chitalia V; Han J; Seta F
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):e339-e357. PubMed ID: 37288573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered tissue behavior of a non-aneurysmal descending thoracic aorta in the mouse model of Marfan syndrome.
    Haskett D; Doyle JJ; Gard C; Chen H; Ball C; Estabrook MA; Encinas AC; Dietz HC; Utzinger U; Vande Geest JP; Azhar M
    Cell Tissue Res; 2012 Jan; 347(1):267-77. PubMed ID: 22105919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan?
    Matt P; Habashi J; Carrel T; Cameron DE; Van Eyk JE; Dietz HC
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):389-94. PubMed ID: 18242274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome.
    Emrich FC; Okamura H; Dalal AR; Penov K; Merk DR; Raaz U; Hennigs JK; Chin JT; Miller MO; Pedroza AJ; Craig JK; Koyano TK; Blankenberg FG; Connolly AJ; Mohr FW; Alvira CM; Rabinovitch M; Fischbein MP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):146-54. PubMed ID: 25359856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress.
    Yang HH; van Breemen C; Chung AW
    Vascul Pharmacol; 2010; 52(1-2):37-45. PubMed ID: 19879959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens Accentuate TGF-β Dependent Erk/Smad Activation During Thoracic Aortic Aneurysm Formation in Marfan Syndrome Male Mice.
    Tashima Y; He H; Cui JZ; Pedroza AJ; Nakamura K; Yokoyama N; Iosef C; Burdon G; Koyano T; Yamaguchi A; Fischbein MP
    J Am Heart Assoc; 2020 Oct; 9(20):e015773. PubMed ID: 33059492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.